BRD7-IN-1 free base is primarily utilized in biochemical research as a selective inhibitor targeting the bromodomain-containing protein 7 (BRD7). Its application is significant in studying the role of BRD7 in various cellular processes, particularly in chromatin remodeling and gene expression regulation. Researchers employ this compound to investigate its potential effects on cancer biology, as BRD7 is implicated in tumor suppression and oncogenic pathways. Additionally, it is used to explore therapeutic strategies for diseases where epigenetic regulation is disrupted, such as certain cancers and inflammatory conditions. The compound serves as a valuable tool for understanding the molecular mechanisms of BRD7 and its interactions within cellular systems.